Discussions on PMP Should Go Beyond Its Scope: JMA’s Imamura

JMA Vice President Satoshi Imamura Policymakers should hold broader discussions on the so-called price maintenance premium (PMP) for on-patent medicines, going beyond the topic of whether to narrow down the scope of eligible products and companies, Satoshi Imamura, vice president...read more